BIOTECHNOLOGY


CHMP recommends EU marketing approval of ten drugs

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended seven medicines for approval, including two orphan medicines, plus three generics at its November 2017 meeting.

FDA lifts clinical hold on Cellectis Phase I trials

The US Food and Drug Administration (FDA) has lifted the clinical hold due to a patient death on Phase I testing of UCART123 in acute myeloid leukemia (AML) and blastic...

European biotech stocks: New wave of optimism

In 2017, the European biotech sector witnessed a volume increase in IPOs and follow-on financings. This says the most recent capital market report of BIOCOM which is published during BIO-Europe...

Blocking antibody recycling vs autoimmune diseases

Researchers at Belgian UCB SA have clinically demonstrated that an antibody targeting a normal cellular recycling process can remove autoantibodies from the blood of people with autoimmune diseases. In...

11th Berlin Conference on Life Sciences: Novel antimicrobials and AMR...

02.03.2018 Over it’s ten year’s history, the Berlin Conference has become a must-attend event for Life Science decision makers, business developers, investors and legal experts. The 11th conference will...

Uniqure readies share stock offering

Dutch Uniqure BV launched a public offering of five million shares of common stock. Underwriters over-allotment will be an additional 750,000 shares. Following up on its well-received lead programme switch,...

ADC Therapeutics raises US$200m in private financing

Swiss cancer antibody-drug conjugate (ADC) developer ADC Therapeutics Sarl (Epalinges) has raised US$200m million through an oversubscribed private placement. Investors  include Auven Therapeutics, Redmile, the Wild Family Office and its...
Biotechnology : nature.com


Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.

Structure-guided chemical modification of guide RNA enables potent non-viral <i>in...

Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editingStructure-guided chemical modification of guide RNA enables potent non-viral <i>in vivo</i> genome editing, Published online: 13 November 2017;...

Accurate assembly of transcripts through phase-preserving graph decomposition

Accurate assembly of transcripts through phase-preserving graph decompositionAccurate assembly of transcripts through phase-preserving graph decomposition, Published online: 13 November 2017; doi:10.1038/nbt.4020Scallop improves identification of multi-exon and transcripts expressed at low...

Three-dimensional map of nonhematopoietic bone and bone-marrow cells and molecules

Three-dimensional map of nonhematopoietic bone and bone-marrow cells and moleculesThree-dimensional map of nonhematopoietic bone and bone-marrow cells and molecules, Published online: 13 November 2017; doi:10.1038/nbt.4006A compendium detailing the localization of...

Public views on gene editing and its uses

Public views on gene editing and its usesPublic views on gene editing and its uses, Published online: 09 November 2017; doi:10.1038/nbt.3958

First rounders: Stelios Papadopoulos

First rounders: Stelios PapadopoulosFirst rounders: Stelios Papadopoulos, Published online: 09 November 2017; doi:10.1038/nbt.3995

Spanish group defeats Shkreli in Chagas voucher race

Spanish group defeats Shkreli in Chagas voucher raceSpanish group defeats Shkreli in Chagas voucher race, Published online: 09 November 2017; doi:10.1038/nbt1117-1003

Ethical principles for the use of human cellular biotechnologies

Ethical principles for the use of human cellular biotechnologiesEthical principles for the use of human cellular biotechnologies, Published online: 09 November 2017; doi:10.1038/nbt.4007Recent developments in bioengineering promise the possibility of...

Duchenne drug clings on for FDA nod

Duchenne drug clings on for FDA nodDuchenne drug clings on for FDA nod, Published online: 09 November 2017; doi:10.1038/nbt1117-999